MetLife Investment Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $654K | Buy |
40,900
+5,805
| +17% | +$92.9K | ﹤0.01% | 1553 |
|
|
2025
Q1 | $600K | Sell |
35,095
-553
| -2% | -$9.45K | ﹤0.01% | 1632 |
|
|
2024
Q4 | $883K | Buy |
35,648
+2,040
| +6% | +$50.5K | ﹤0.01% | 1481 |
|
|
2024
Q3 | $958K | Hold |
33,608
| – | – | 0.01% | 1414 |
|
|
2024
Q2 | $887K | Buy |
33,608
+5,131
| +18% | +$135K | 0.01% | 1411 |
|
|
2024
Q1 | $920K | Hold |
28,477
| – | – | 0.01% | 1343 |
|
|
2023
Q4 | $1.2M | Hold |
28,477
| – | – | 0.01% | 1205 |
|
|
2023
Q3 | $1.09M | Hold |
28,477
| – | – | 0.01% | 1182 |
|
|
2023
Q2 | $540K | Buy |
28,477
+6,087
| +27% | +$115K | ﹤0.01% | 1648 |
|
|
2023
Q1 | $347K | Buy |
22,390
+743
| +3% | +$11.5K | ﹤0.01% | 1869 |
|
|
2022
Q4 | $384K | Hold |
21,647
| – | – | ﹤0.01% | 1814 |
|
|
2022
Q3 | $121K | Buy |
+21,647
| New | +$121K | ﹤0.01% | 2583 |
|
|
2022
Q2 | – | Sell |
-25,184
| Closed | -$139K | – | 2883 |
|
|
2022
Q1 | $139K | Buy |
25,184
+20,377
| +424% | +$112K | ﹤0.01% | 2546 |
|
|
2021
Q4 | $41K | Sell |
4,807
-10,202
| -68% | -$86.9K | ﹤0.01% | 2470 |
|
|
2021
Q3 | $130K | Buy |
15,009
+10,800
| +257% | +$93.9K | ﹤0.01% | 2322 |
|
|
2021
Q2 | $44.5K | Sell |
4,209
-10,798
| -72% | -$114K | ﹤0.01% | 2425 |
|
|
2021
Q1 | $241K | Hold |
15,007
| – | – | ﹤0.01% | 1955 |
|
|
2020
Q4 | $693K | Hold |
15,007
| – | – | 0.01% | 1310 |
|
|
2020
Q3 | $528K | Buy |
15,007
+5,560
| +59% | +$196K | 0.01% | 1340 |
|
|
2020
Q2 | $230K | Buy |
+9,447
| New | +$230K | ﹤0.01% | 1821 |
|